Abselion Mar 9 2026 Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced that it has established a US subsidiary at The Engine in Cambridge, MA. The new location strengthens its presence in the North American life sciences ecosystem, providing a formal base to support more direct engagement with academic, biotech, and pharma research teams working across biologics characterization and development workflows. The US site will